Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Egansbay
    Member
    • Jan 2015
    • 23

    16S V4 amplicon concentration after first PCR step

    Dear all

    I am analyzing gut samples from fish using illumina's 16S protocol, amplifying the v4 hypervariable region. I am getting ok bands after the first PCR step, and a nice peak on the agilent bioanalyzer (approx. 350bp). I am wondering however, after purification of products, what is an acceptable concentration for each sample? I am getting concentrations of individual products of between 0.5 and 9ng/ul, with the average being around 2-4ng/ul per sample. Is this an acceptable concentration to proceed with?

    Thank you very much in advance.

    Kind regards

    Egansbay
  • microgirl123
    Senior Member
    • Jun 2012
    • 199

    #2
    Hi Egansbay,

    I usually quantify my first round PCR products with Qubit and then try to add 50 ng of total DNA to the second round of PCR for 5 cycles. If my concentrations are much too low to do that, I add up to 3 more cycles of PCR.

    Comment

    • Egansbay
      Member
      • Jan 2015
      • 23

      #3
      Thank you microgirl. So in your experience are my concentrations of product too low to proceed with second round pcr?

      Comment

      • microgirl123
        Senior Member
        • Jun 2012
        • 199

        #4
        If you had good bands in the first place, I would go ahead and give it a try - you can always do a few samples first. I use an adaptation of the Illumina method with a 50 ul PCR volume, up to 15 ul of cleaned template, and 5-8 cycles of PCR.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        29 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        212 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        78 views
        0 reactions
        Last Post SEQadmin2  
        Working...